Significance: Ascorbic acid and sodium-dependent vitamin C transporters (SVCT) have been shown to have important functions in the peripheral nervous system (PNS). Ascorbic acid is known to promote myelination in vitro in Schwann cell/dorsal root ganglion co-cultures by the formation of a collagen- and laminin-containing extracellular matrix. Recent Advances: Recently, the function of ascorbic acid and SVCT2 in the PNS has been shown in vivo as well. Several studies on ascorbic acid treatment of Charcot-Marie-Tooth neuropathy 1A (CMT1A) have been completed and showed no clinical benefit. Critical Issues: Possible reasons for the failure of ascorbic acid in CMT1A treatment are discussed in this review. More preclinical trials, ideally using different animal models, should be considered before the initiation of clinical trials in humans. More knowledge about ascorbic acid transport kinetics and inter-individual differences in humans is necessary for future studies. Future Directions: Further research into ascorbic acid transport mechanisms in the PNS is warranted. Especially the effects of transgenic or pharmacologic SVCT2 up-regulation on PNS myelination and remyelination will be an interesting area of research in the future. Furthermore, the potential use of ascorbic acid for peripheral neuropathies other than CMT1A would be a possible future research direction. Antioxid. Redox Signal. 19, 2105–2114.
Get full access to this article
View all access options for this article.
References
1.
AmanoA, AigakiT, MaruyamaN, and IshigamiA. Ascorbic acid depletion enhances expression of the sodium-dependent vitamin C transporters, SVCT1 and SVCT2, and uptake of ascorbic acid in livers of SMP30/GNL knockout mice. Arch Biochem Biophys, 496: 38–44, 2010.
2.
Baron-Van EvercoorenA, GansmullerA, GumpelM, BaumannN, and KleinmanHK. Schwann cell differentiation in vitro: extracellular matrix deposition and interaction. Dev Neurosci, 8: 182–196, 1986.
3.
BergRA, SteinmannB, RennardSI, and CrystalRG. Ascorbate deficiency results in decreased collagen production: under-hydroxylation of proline leads to increased intracellular degradation. Arch Biochem Biophys, 226: 681–686, 1983.
4.
BoentertM, DziewasR, HeidbrederA, HappeS, KleffnerI, EversS, and YoungP. Fatigue, reduced sleep quality and restless legs syndrome in Charcot-Marie-Tooth disease: a web-based survey. J Neurol, 257: 646–652, 2010.
5.
BornsteinSR, Yoshida-HiroiM, SotiriouS, LevineM, HartwigHG, NussbaumRL, and EisenhoferG. Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). Faseb J, 17: 1928–1930, 2003.
6.
BoyerJC, CampbellCE, SigurdsonWJ, and KuoSM. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem Biophys Res Commun, 334: 150–156, 2005.
7.
BraathenGJ, SandJC, LobatoA, HoyerH, and RussellMB. Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol, 18: 39–48, 2012.
8.
BradleyJL, KingRH, MuddleJR, and ThomasPK. The extracellular matrix of peripheral nerve in diabetic polyneuropathy. Acta Neuropathol, 99: 539–546, 2000.
9.
BurnsJ, OuvrierRA, YiuEM, JosephPD, KornbergAJ, FaheyMC, and RyanMM. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol, 8: 537–544, 2009.
10.
CaprileT, SalazarK, AstuyaA, CisternasP, Silva-AlvarezC, MontecinosH, MillanC, de Los Angeles GarciaM, and NualartF. The Na+-dependent L-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids. J Neurochem, 108: 563–577, 2009.
11.
CastroM, CaprileT, AstuyaA, MillanC, ReinickeK, VeraJC, VasquezO, AguayoLG, and NualartF. High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem, 78: 815–823, 2001.
12.
DziewasR, WaldmannN, BontertM, HorH, MullerT, OkegwoA, RingelsteinEB, and YoungP. Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study. J Neurol Neurosurg Psychiatry, 79: 829–831, 2008.
13.
EldridgeCF, BungeMB, and BungeRP. Differentiation of axon-related Schwann cells in vitro: II. Control of myelin formation by basal lamina. J Neurosci, 9: 625–638, 1989.
14.
EldridgeCF, BungeMB, BungeRP, and WoodPM. Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol, 105: 1023–1034, 1987.
15.
FoleyC, SchofieldI, EglonG, BaileyG, ChinneryPF, and HorvathR. Charcot-Marie-Tooth disease in Northern England. J Neurol Neurosurg Psychiatry, 83: 572–573, 2012.
16.
Garcia MdeL, SalazarK, MillanC, RodriguezF, MontecinosH, CaprileT, SilvaC, CortesC, ReinickeK, VeraJC, AguayoLG, OlateJ, MolinaB, and NualartF. Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells. Glia, 50: 32–47, 2005.
17.
GeesinJC, DarrD, KaufmanR, MuradS, and PinnellSR. Ascorbic acid specifically increases type I and type III procollagen messenger RNA levels in human skin fibroblast. J Invest Dermatol, 90: 420–424, 1988.
18.
GessB, LohmannC, HalfterH, and YoungP. Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into Schwann cells. Glia, 58: 287–299, 2010.
19.
GessB, RohrD, FledrichR, SeredaMW, KleffnerI, HumbergA, NowitzkiJ, StreckerJK, HalfterH, and YoungP. Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. J Neurosci, 31: 17180–17192, 2011.
20.
GispertS, DutraA, LiebermanA, FriedlichD, and NussbaumRL. Cloning and genomic organization of the mouse gene slc23a1 encoding a vitamin C transporter. DNA Res, 7: 339–345, 2000.
21.
HarrisonFE, DawesSM, MeredithME, BabaevVR, LiL, and MayJM. Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2. Free Radic Biol Med, 49: 821–829, 2010.
22.
HarrisonFE and MayJM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med, 46: 719–730, 2009.
23.
HayasakaK, HimoroM, SatoW, TakadaG, UyemuraK, ShimizuN, BirdTD, ConneallyPM, and ChancePF. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet, 5: 31–34, 1993.
24.
HolmbergBH. Charcot-Marie-Tooth disease in northern Sweden: an epidemiological and clinical study. Acta Neurol Scand, 87: 416–422, 1993.
25.
HuxleyC, PassageE, MansonA, PutzuG, Figarella-BrangerD, PellissierJF, and FontesM. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet, 5: 563–569, 1996.
26.
IonasescuV, SearbyC, and IonasescuR. Point mutations of the connexin32 (GJB1) gene in X-linked dominant Charcot-Marie-Tooth neuropathy. Hum Mol Genet, 3: 355–358, 1994.
27.
JohnstonL and LavertyG. Vitamin C transport and SVCT1 transporter expression in chick renal proximal tubule cells in culture. Comp Biochem Physiol A Mol Integr Physiol, 146: 327–334, 2007.
KayaF, BelinS, DiamantidisG, and FontesM. Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions?. FEBS Lett, 582: 3614–3618, 2008.
30.
KayaF, BelinS, MicallefJ, BlinO, and FontesM. Analysis of the benefits of vitamin cocktails in treating Charcot-Marie-Tooth disease type 1A. Muscle Nerve, 38: 1052–1054, 2008.
31.
KorcokJ, YanR, SiushansianR, DixonSJ, and WilsonJX. Sodium-ascorbate cotransport controls intracellular ascorbate concentration in primary astrocyte cultures expressing the SVCT2 transporter. Brain Res, 881: 144–151, 2000.
32.
LupskiJR, de Oca-LunaRM, SlaugenhauptS, PentaoL, GuzzettaV, TraskBJ, Saucedo-CardenasO, BarkerDF, KillianJM, GarciaCA, ChakravartiA, and PatelPI. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell, 66: 219–232, 1991.
33.
MacDonaldL, ThumserAE, and SharpP. Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br J Nutr, 87: 97–100, 2002.
34.
MatsunamiN, SmithB, BallardL, LenschMW, RobertsonM, AlbertsenH, HanemannCO, MullerHW, BirdTD, WhiteR, et al. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nat Genet, 1: 176–179, 1992.
35.
MicallefJ, AttarianS, DubourgO, GonnaudPM, HogrelJY, StojkovicT, BernardR, JouveE, PitelS, VacherotF, RemecJF, JomirL, AzabouE, Al-MoussawiM, LefebvreMN, AttoliniL, YaiciS, TanesseD, FontesM, PougetJ, and BlinO. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol, 8: 1103–1110, 2009.
36.
MunGH, KimMJ, LeeJH, KimHJ, ChungYH, ChungYB, KangJS, HwangYI, OhSH, KimJG, HwangDH, ShinDH, and LeeWJ. Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J Neurosci Res, 83: 919–928, 2006.
37.
OlsenCL and BungeRP. Requisites for growth and myelination of urodele sensory neurons in tissue culture. J Exp Zool, 238: 373–384, 1986.
38.
PareysonD and MarchesiC. Natural history and treatment of peripheral inherited neuropathies. Adv Exp Med Biol, 652: 207–224, 2009.
39.
PareysonD, ReillyMM, SchenoneA, FabriziGM, CavallaroT, SantoroL, VitaG, QuattroneA, PaduaL, GemignaniF, VisioliF, LauraM, RadiceD, CalabreseD, HughesRA, and SolariA. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol, 10: 320–328, 2011.
40.
PassageE, NorreelJC, Noack-FraissignesP, SanguedolceV, PizantJ, ThirionX, Robaglia-SchluppA, PellissierJF, and FontesM. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med, 10: 396–401, 2004.
41.
QiaoH and MayJM. Development of ascorbate transporters in brain cortical capillary endothelial cells in culture. Brain Res, 1208: 79–86, 2008.
42.
SaviniI, RossiA, PierroC, AviglianoL, and CataniMV. SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids, 34: 347–355, 2008.
43.
ShyME, BlakeJ, KrajewskiK, FuerstDR, LauraM, HahnAF, LiJ, LewisRA, and ReillyM. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology, 64: 1209–1214, 2005.
44.
SkreH. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet, 6: 98–118, 1974.
45.
SolariA, LauraM, SalsanoE, RadiceD, and PareysonD. Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord, 18: 19–26, 2008.
46.
SotiriouS, GispertS, ChengJ, WangY, ChenA, Hoogstraten-MillerS, MillerGF, KwonO, LevineM, GuttentagSH, and NussbaumRL. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med, 8: 514–517, 2002.
47.
StratakisCA, TaymansSE, DaruwalaR, SongJ, and LevineM. Mapping of the human genes (SLC23A2 and SLC23A1) coding for vitamin C transporters 1 and 2 (SVCT1 and SVCT2) to 5q23 and 20p12, respectively. J Med Genet, 37: E20, 2000.
48.
TajimaS and PinnellSR. Ascorbic acid preferentially enhances type I and III collagen gene transcription in human skin fibroblasts. J Dermatol Sci, 11: 250–253, 1996.
49.
TajimaS and PinnellSR. Regulation of collagen synthesis by ascorbic acid. Ascorbic acid increases type I procollagen mRNA. Biochem Biophys Res Commun, 106: 632–637, 1982.
50.
TimmermanV, NelisE, Van HulW, NieuwenhuijsenBW, ChenKL, WangS, Ben OthmanK, CullenB, LeachRJ, HanemannCO, et al. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet, 1: 171–175, 1992.
51.
ValentijnLJ, BolhuisPA, ZornI, HoogendijkJE, van den BoschN, HenselsGW, StantonVPJr., HousmanDE, FischbeckKH, RossDA, et al. The peripheral myelin gene PMP-22/GAS-3 is duplicated in Charcot-Marie-Tooth disease type 1A. Nat Genet, 1: 166–170, 1992.
52.
VerhammeC, de HaanRJ, VermeulenM, BaasF, de VisserM, and van SchaikIN. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial. BMC Med, 7: 70, 2009.
53.
WangY, MackenzieB, TsukaguchiH, WeremowiczS, MortonCC, and HedigerMA. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun, 267: 488–494, 2000.
54.
WarnerLE, GarciaCA, and LupskiJR. Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanisms. Annu Rev Med, 50: 263–275, 1999.
55.
ZuchnerS, MersiyanovaIV, MugliaM, Bissar-TadmouriN, RochelleJ, DadaliEL, ZappiaM, NelisE, PatitucciA, SenderekJ, ParmanY, EvgrafovO, JonghePD, TakahashiY, TsujiS, Pericak-VanceMA, QuattroneA, BattalogluE, PolyakovAV, TimmermanV, SchroderJM, and VanceJM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet, 36: 449–451, 2004.
